hat
Hepatotoxicity: Byenke oralman ke yo bay, kote Ostarine pa genyen ladan li toksisite fwa. MK 2866 pa fè pati pou klas C17-alpha alkylated (C17-aa) a dwòg tankou anpil bouch ou stéroïdes. Li pa en MI métabolite asosye ak S4 SARM k ap bay sa an patikilye SARM kèk aktivite è.
eng
Hepatotoxicity: Although orally administered, the side effects of Ostarine do not include liver toxicity. MK 2866 does not belong to the C17-alpha alkylated (C17-aa) class of drugs like many oral anabolic steroids. It does not mirror the MI metabolite associated with the SARM S4 that gives that particular SARM some hepatic activity.